- Published: 07 September 2012
- Written by Editor
Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11 at 10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific time in the Starlight North room of the Waldorf-Astoria Hotel.
The presentation with slides will be webcast live and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.
Annual Rodman & Renshaw Global Investment Conference
CTI presentation: Tuesday, September 11, 2012
10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific
Starlight North, Waldorf-Astoria Hotel
|
Media contact: |
Investors contact: |
|
Cell Therapeutics, Inc. |
Cell Therapeutics, Inc. |
|
Dan Eramian |
Ed Bell |
|
T: 206.272.4343 |
T: 206.272.4345 |
|
F: 206.272.4434 |
E: This email address is being protected from spambots. You need JavaScript enabled to view it. |
|
E: This email address is being protected from spambots. You need JavaScript enabled to view it. |
|
